To include your compound in the COVID-19 Resource Center, submit it here.

Revlimid lenalidomide: data

Pooled data from 11 trials showed that the incidence of second primary malignancies in 3,846 patients ages 29-92 receiving

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE